Insomnia Chronic Completed Phase 4 Trials for Zolpidem (DB00425)

Also known as: Chronic Insomnia / Insomnia / Sleeplessness / Insomnia NOS

IndicationStatusPhase
DBCOND0080650 (Insomnia Chronic)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00492232Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic InsomniaTreatment